Sign Up to like & get
recommendations!
0
Published in 2019 at "Current Pharmaceutical Design"
DOI: 10.2174/1381612825666190619145025
Abstract: Background: Isoproterenol (ISO) is a non-selective β-adrenergic agonist. Our aims were to investigate the autophagy and cell death pathways including apoptosis and necrosis in ISO-induced car-diac injury in a dose-dependent manner. Methods: Male Sprague-Dawley rats…
read more here.
Keywords:
iso iso;
isoproterenol;
iso;
dose dependent ... See more keywords